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The spread of bacterial resistance to traditional antibiotics continues to stimulate the search for alternative
antimicrobial strategies. All forms of life, from bacteria to humans, are postulated to rely on a fundamental
host defense mechanism, which exploits the formation of open pores in microbial phospholipid bilayers.
Here we predict that transmembrane poration is not necessary for antimicrobial activity and reveal
a distinct poration mechanism that targets the outer leaﬂet of phospholipid bilayers. Using a combination
of molecular-scale and real-time imaging, spectroscopy and spectrometry approaches, we introduce
a structural motif with a universal insertion mode in reconstituted membranes and live bacteria. We
demonstrate that this motif rapidly assembles into monolayer pits that coalesce during progressive
membrane exfoliation, leading to bacterial cell death within minutes. The ﬁndings oﬀer a new physical
basis for designing eﬀective antibiotics.Introduction
Membrane poration is fundamental to cell function.1 Bacterial
exotoxins (cytolysins) porate phago- and hemocytes,2 cytolytic
mediators (perforins) form transmembrane channels in infec-
ted and neoplastic cells to activate intrinsic suicide programs,3
and large nuclear pore complexes that cross the nuclear enve-
lope facilitate transport in and out of the cell nucleus.4 The
spread of antimicrobial resistance re-emphasizes poration as
a means of counteracting opportunistic infections, with
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hemistry 2017antimicrobial peptides (AMPs).5 The peptides, of which there
are >1000 reported to date,6 preferentially bind to anionic
microbial membranes in which they fold into amphipathic
structures by partitioning cationic and hydrophobic amino-acid
side chains.7 This property enables them to assemble into
transmembrane structures that coalesce into permanent, tran-
sient or expanding pores.8–10 Poration mechanisms vary but all
appear to involve an inactive surface-bound (“S”) state followed
by a pore-like insertion (“I”) state.11 Peptide monomers are
distributed both on and in membranes and tend to bind more
strongly to the edges of forming pores,12 promoting pore
expansion and merger.10 Membrane thinning and positive
curvature may precede poration,13 which at non-antimicrobial
concentrations of AMPs can induce small transient pores
without causing cell lysis.14 At antimicrobial concentrations, the
exposed outer monolayer may alone support the progressive
migration of peptide monomers.10,15 The rate and mode of
migration, with or without poration, can then be facilitated by
the relative orientation of the monomers to the membrane
surface, which can allow them to remain positioned in the
monolayer16 or in the interface.17 Indeed, AMPs adopt diﬀerent
orientations in membranes that range from at and perpen-
dicular to oblique or tilted,12,16,18 while peptide lengths oen
exceed the thickness of the bilayer or are too short to span it.7
Consequently, tilted conformations may oﬀer structural motifs
that are predisposed to monolayer rather than bilayer poration.
Transmembrane pores form hydrophilic channels that interfaceChem. Sci., 2017, 8, 1105–1115 | 1105
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
6 
Se
pt
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
7/
02
/2
01
7 
16
:2
4:
28
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinethe extra- and intra-cellular environments, both of which are
aqueous. These pores can equilibrate, stabilize and expand. In
contrast, monolayer pores expose the hydrophobic core of the
bilayer to water. Such an energetically unfavorable congura-
tion, which may only partially be compensated by peptide-water
networks formed in the monolayer,19 would cause complex
changes that microbial membranes cannot accommodate thus
inducing a cost of fast and strong antimicrobial eﬀects. Here we
test this prediction and provide the rst direct evidence of the
phenomenon.Results and discussion
Design rationale
Our approach adapts the principles of “inverse protein folding”20
by designing an antimicrobial sequence that folds with the
formation of a desired structure, a monolayer pore. The sequence
used here is an archetypal AMP that was converted from an
antimicrobial helical insert (amhelin)10 into a tilted antimicrobial
insert (tilamin). Both peptides comprise neutral polar or small
(N), polar cationic (C) and hydrophobic (H) residues that arrange
into a contiguous amphipathic helix of 3.15 nm in length
(0.54 nm per helical turn)21 (Fig. 1A). This arrangement allows the
helix to span microbial phospholipid bilayers of 3–4 nm in
thickness.22–24 However, unlike transmembrane amhelin,10 the
tilamin helix has to insert only half-way through the bilayer
(Fig. 1B). To achieve this, tilamin was designed to exploit charge
interplays with phospholipids25 while adopting a tilted orienta-
tion in the outer leaet of the bilayer (Fig. 1B).Fig. 1 Tilted antimicrobial helix (tilamin): design and proposed
mechanism ofmembrane insertion. (A, top) Peptide sequences aligned
with helical repeats, CNCHNCH, in which hydrophobic residues are
separated at i, i + 3 and i, i + 4 helical spacings. Cationic lysines and
arginines are in blue and dark blue, respectively, anionic residues in red
and absolute identities in yellow. (A, bottom) Tilamin sequence
conﬁgured onto an a-helical wheel with 3.6 residues per turn. Cationic
residues are in blue and the hydrophobic face is underlined. Alanines
deuterated for GALA scans are in red. Note: the helical wheel does not
reﬂect the exact spread of the side chains. (B) Schematics of pore
edges showing depths of insertion for proposed monolayer and
transmembrane poration mechanisms. For clarity, only one peptide
(blue cylinder) and one phospholipid per layer are shown (aliphatic
chains in grey, headgroups in pink).
1106 | Chem. Sci., 2017, 8, 1105–1115These peptide–phospholipid charge interplays derive from
diﬀerences between cationic lysine and arginine residues,
which are primary electrostatic binders to anionic microbial
membranes. These amino acids have diﬀerent chemistries and
diﬀerent free energies of hydration, but both have to overcome
the same free energy barrier when crossing membranes in
protonated forms. For neutral lysine, which in membranes can
remain deprotonated, the barrier is lower than that for neutral
arginine.25 Therefore, protonated arginines are favored at all
stages of membrane insertion, and starting with surface
binding they maintain extensive hydrogen-bonding networks
that trap more phosphate and water.16,25 Each arginyl residue
can provide ve hydrogen-bond donors stabilizing peptide–
phosphate clusters and thereby enhancing the aﬃnity between
the peptide and the membrane. To enable the formation of
electrostatic networks along the helix while inserting in
membranes, arginines were evenly distributed in the tilamin
sequence. A high concentration of arginines was allowed in the
central part of the peptide to arrest its interfacial binding,
which was further stabilized by the short hydrophobic face
(Fig. 1A).10 To avoid undesired hemolytic eﬀects common for
venom peptides (melittin) that have broad hydrophobic
faces,7,10 the charge-hydrophobic contributions to the binding
were balanced at a 1.5 : 1 ratio by splitting the polar face into
two unequal sub-faces via a neutral alanyl cluster placed
opposite to the hydrophobic face. A bulky and hydrophobic
tyrosine with propensity for slight b-bends was incorporated
into the alanyl cluster in the central part of the helix to help the
termini adapt to membrane curvature. The resulting sequence
comprises three helical heptads, CNCHNCH, which arrange the
same-type residues (i and i + 7 spacing) next to one another
when viewed along the helical axis. This spacing contains i, i + 3
and i, i + 4 helical patterns characteristic of canonical coiled
coils, known to maintain interfacial contacts in a highly coop-
erative manner,24 and thus able to support cooperative tilamin
assembly in lipid bilayers. Since tilamin is a helical design, all
amino acids used have high helical propensity. Finally, an
anionic version of tilamin was designed as a non-AMP control
(Fig. 1A). This control is important for two reasons. Firstly, the
peptide has helical propensity that is comparable to that of
tilamin. But, secondly, it lacks the ability to bind to membranes
and thence cannot undergo folding-mediated insertion into
bacterial lipid bilayers, which renders it non-antimicrobial.
Thus, all three designed peptides are cross-referenced controls,
with each responsible for a specic mode of interactions with
microbial membranes: from no interactions (non-AMP) to
folding-mediated transmembrane (amhelin) and monolayer
(tilamin) poration.Measurement strategy: a molecular-cellular scale continuum
To experimentally test the hypothesis of monolayer poration
requires a combinatory approach comprising diﬀerent
measurement methods that are best performed in a continuum
across relevant length scales. Given that individual methods
have their own limitations and advantages, each measurement
can address a specic peptide property, physico-chemical,This journal is © The Royal Society of Chemistry 2017
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View Article Onlinemechanistic or biological, and at given length and temporal
scales. In such a continuum, all methods are posed to generate
ndings that complement one another, which help to compile
information as exhaustive as necessary for the demonstration of
the phenomenon. With this in mind, we fully characterized the
behavior of tilamin in biological and model membrane envi-
ronments by performing complementary measurements in
a molecular-to-cellular scale continuum, while providing
computational atomistic and molecular descriptions of mono-
layer pore formation. Fig. 2 schematically illustrates our
measurement strategy.Biological activity
Consistent with design, tilamin was found to be non-hemolytic
and antimicrobial, with Minimum Inhibitory Concentrations
(MIC) typical of polypeptide antibiotics, while the non-AMP was
biologically inactive (Table S1 in ESI†).
Tilamin exhibited comparably strong activities against all
the bacteria tested with no apparent preference for Gram
positive or Gram negative bacteria. By contrast, the activities of
amhelin and a naturally occurring AMP, cecropin B,26 were less
consistent across diﬀerent bacteria: Gram positive bacteria
tended to be more tolerant to these two peptides and both
these peptides were inactive against S. aureus (Table S1†). The
diﬀerences did not appear systematic and varied from one
bacterium type to another, which may be attributed to revers-
ible or phenotypic tolerance to antibiotics.27,28 Similar trends
were observed for commercial membrane-active polypeptide
antibiotics, daptomycin and polymyxin B, which can prefer-
entially target Gram positive and Gram negative membranes,
respectively (Table S1†). Although daptomycin was inactive
against Gram negative bacteria, while polymyxin B was toxic toFig. 2 Measurement continuum. A schematic representation of a mole
antimicrobial monolayer poration. Key: cwEPR: continuous wave electr
chromatography mass spectrometry, NMR: nuclear magnetic resonance
This journal is © The Royal Society of Chemistry 2017all of these, E. faecalis proved to be tolerant to both antibiotics
(Table S1†). Further, tilamin and daptomycin were the only
agents with appreciable activity against S. aureus, though
daptomycin proved to be marginally hemolytic (Table S1†).
Given that among the tested antibiotics only tilamin was non-
diﬀerentially antimicrobial, the observed variations suggest
that the peptide should exhibit a distinctive antimicrobial
mechanism.7 In native environments AMPs are secreted to
respond to microbial challenge within their proteolytic life
time (minutes). Therefore, the mechanism should become
apparent within the same timescale. MIC assays are not suit-
able in this regard as these are optical density measurements
performed over much longer periods of time (24 hours) and
take no account of changes at the cellular level. To mitigate
this, we sought additional evidence.
Firstly, we monitored bacterial cell death by live-dead
assays using uorescence microscopy.10,26 Tilamin caused up
to 80% lysis rates at the MIC within the rst 30 min for E. coli
(Fig. S1†). These were noticeably faster than those of cecropin
B and amhelin (both <30%) in the same timeframe, while
comparable rates were only seen for amhelin at concentra-
tions three times above MIC (Fig. S1†). Secondly, to better
understand the mechanistic basis of the killing kinetics we
monitored individual cell lysis by time-lapse atomic force
microscopy (AFM) in water. Gram negative bacteria, such as
E. coli, present ideal models for this purpose.29 These cells
have two distinct membranes (outer and inner or cyto-
plasmic) with the bilayer thicknesses of 3.7–4.1 nm.23 A thin
and highly porous peptidoglycan layer (4 nm) separates
the two membranes,30 but cannot protect the inner
membrane.31 Moreover, the layer exhibits high aﬃnity to
cationic AMPs thereby facilitating their entry to the cyto-
plasmic membrane.32cular-to-cellular scale measurement continuum used to demonstrate
on paramagnetic resonance, MS: mass spectrometry, LC-MS: liquid-
spectroscopy.
Chem. Sci., 2017, 8, 1105–1115 | 1107
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View Article OnlineTherefore, if tilamin causes poration it should aﬀect both
membranes. Consequently, in the context of monolayer poration,
one should distinguish the eﬀect of the peptide on the outer
leaets, which are present in both outer and inner membranes,
from that on the outer membranes. This may prove to be
important as the outer membranes are aﬀected rst, which is
likely to be associated with their more apparent or advanced
removal during tilamin treatment.
Monolayer poration in live bacteria and progressive removal
of the outer membranes
Indeed, this was observed. AFM revealed the progressive
removal of the outer membrane of E. coli within the rst
minutes of tilamin treatment (Fig. 3, S2A and B†). FluorescenceFig. 3 Monolayer poration and progressive membrane removal in live ba
water taken at the ﬁrst 780 s incubation with tilamin. Inset in height imag
bacterium, showing 8 nm-deep steps from the outer cell-wall layer to
(3.7–4.1 nm)23 and a periplasmic peptidoglycan layer (4 nm). (B) High re
boxes in (A), after correction for background curvature in the height data
poration in both outer and innermembrane. (C) Height proﬁles taken alon
subtraction (bottom). These data show the depth proﬁles of individual po
tilamin, as a function of time (for the corresponding height images, see F
since injection. Colour scale for height data, see (A) 140 nm (A) and 19 n
1108 | Chem. Sci., 2017, 8, 1105–1115microscopy conrmed a nearly complete lysis of E. coli cells
within 15 min, which agreed well with the results from the live-
dead assays (Fig. S2C†). A clear separation between the inner
and outer membranes was also evident. The height of the
separation matched the expected depth of the outer cell-wall
layer when the outer membrane and peptidoglycan are
combined (8 nm) (Fig. 3A). In both outer and inner
membranes, pore-like features with depths of 2 nm were
observed during imaging (Fig. 3B, C and S3†). Consistent with
our prediction of monolayer poration, these pores were small,
but abundant, forming rapidly and continuously. This forma-
tion imposed an energetically unfavorable conguration on the
bilayer, which subsequently caused localized membrane
rupture (Fig. 3A–C, S2B and S3†). The latter manifested ascteria. (A) Topographic (height) and phase AFM images of live E. coli in
e: a height proﬁle taken along the black dotted line on the back of the
the inner membrane. The outer layer includes the outer membrane
solution topographic and phase images of the areas marked by white
(see ESI†). These images show exfoliation of the outer membrane and
g the highlighted lines in (B) (top), and after additional local background
res. (D) High resolution phase images of E. coli during incubation with
ig. S2†). Two diﬀerent areas are shown. Time-point labels indicate time
m (B). Incubation conditions: 3.5 mM, pH 7.4, room temperature (rt).
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinedeeper holes or ridges piercing through the membrane layers
(Fig. S3B and C†), as the bacterial membranes disintegrated
within minutes (Fig. 3D, area 2). Taken together, the results
suggest that tilamin elicits rapid antimicrobial responses via
monolayer poration, leading to the fast and progressive disin-
tegration of bacterial membranes.
Up to this point, tilamin was shown to porate both
membranes, but had to aﬀect the outer membranes to induce
visible poration in the inner membranes. As a result, the outer
membranes underwent a more rapid disintegration, prompting
a question of exact pore dynamics in isolated lipid bilayers.
Similarly, the impact of aﬀecting intracellular processes that are
crucial to cell viability cannot be fully excluded in live bacteria
measurements.7 It should be noted however that intracellular
targeting is the consequence of membrane permeabilization
and may not outcompete poration within the observed time-
scale of membrane rupture. Indeed, traditional antibiotics,
which typically engage with intracellular targets, exhibit much
slower killing kinetics that are strictly proportional to the rate of
bacterial growth.33 This is unlike membrane-permeabilizing
AMPs, which attack both growing and mature bacteria.7
Considering the two points together, it was deemed appro-
priate to relate the killing and poration rates in live bacteria
with the membrane-porating eﬀects of tilamin in isolation from
inter-membrane and intracellular processes. To achieve that, we
probed the action of tilamin in reconstituted membranes using
lipid compositions that yield uid-phase membranes at booth
room and physiological temperatures.34Probing outer-leaet poration in reconstituted membranes
Reconstituted membranes were used to investigate the eﬀect of
membrane composition on the binding and activity of tilamin.
Anionic unilamellar vesicles (AUVs) and zwitterionic uni-
lamellar vesicles (ZUVs) provided microbial and mammalian
membrane mimetics, respectively. 1,2-Dilauroyl-sn-glycero-3-
phosphocholine (DLPC) was used to assemble ZUVs, whereas its
3 : 1 molar mixtures with 1,2-dilauroyl-sn-glycero-3-phospho-
(10-rac-glycerol) (DLPG) were used to assemble AUVs. As gauged
by circular dichroism spectroscopy, tilamin was appreciably
helical in AUVs but did not fold in aqueous buﬀers and in ZUVs
(Fig. S4A†). Linear dichroism spectroscopy, which probes rela-
tive peptide orientation to membrane surfaces,35 conrmed
tilamin binding to AUVs. The observed band patterns were
similar to those reported for membrane-inserting aureins and
melittins35,36 indicating helix orientation more parallel to the
membrane normal (Fig. S4B†). As expected, the non-AMP did
not fold or order under any of the conditions used (Fig. 1A and
S4†). The data hence conrms folding-mediated poration by
tilamin in response to microbial membrane binding.
To visualize the process, supported lipid bilayers (SLBs)
were prepared by the surface deposition of the dilauroyl
(DLPC/DLPG, 3 : 1 molar ratio) AUVs on appropriate sub-
strates.10 These preparations had the additional advantage –
compared to whole bacteria – of being at (to within 0.1 nm)
in their unperturbed state, allowing more accurate depth
measurements for tilamin-induced pores by AFM. AFM analysesThis journal is © The Royal Society of Chemistry 2017of SLBs that were xed aer the 15 minutes of tilamin treatment
revealed pore-like structures of varying diameters (Fig. 4A). The
pores tended to fuse into heterogeneous networks suggesting
much faster diﬀusion through the supported membrane matrix
than that of expanding transmembrane pores of amhelin.10
Complementary to these ndings, AFM in aqueous solution
and in real time showed that the networks were complete within
the rst 15 min of incubation at the concentrations used
(Fig. 4B). The pore depths of 1.4 nm were remarkably
consistent in the networks and appeared independent of pore
sizes and incubation times (>2 hours) (Fig. 4A, B, S5A and B†).
This was in contrast to amhelin (Fig. 1A and B) serving for
tilamin as a transmembrane control, which can bind to and fold
in the microbial membranes, but which porates them by
spanning the whole bilayer (Fig. S6†).10 Comparable results of
monolayer poration were obtained for thicker SLBs (4 nm)
assembled as 3 : 1 molar mixtures of 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC) and 1-hexadecanoyl-2-
(9Z-octadecenoyl)-sn-glycero-3-phospho-(10-rac-glycerol) (POPG)
lipids (Fig. S5C†). In these SLBs, similarly sized pores of
1.2–1.8 nm in depth were formed in abundance at the same
time scales as observed on live bacteria and for the DLPC/DLPG
(3 : 1, molar ratio) SLBs. Quantitative analyses of pore size
dynamics measured at diﬀerent depth thresholds showed close
distributions of overlapping pore diameters supporting the
coalescence of individual pores into larger structures and
networks (Fig. S7†). In addition, the coalescence did not have an
appreciable eﬀect on pore depths, with depth values being
universal across all pores, individual and coalescing (Fig. S7†).
These depths agree with the expected diﬀerence between
a bilayer surface and the hydrophobic surface of an inner
monolayer as measured by AFM,37 and thus indicate the local
removal of the outer leaet of the membrane (Fig. 1B).
The pore networks were prone to convert into regions of
higher pore densities, the component specicity of which was
explicitly conrmed by nanoscale resolution secondary-ion
mass spectrometry (NanoSIMS). Fig. 4C shows 12C15N/12C14N
ratio images obtained from the surfaces of the DLPC/DLPG
(3 : 1, molar ratio) SLBs treated with a 15N-labelled tilamin.
Ratios above natural abundance values (0.37%) were evident for
larger pore clusters where the peptide content was the highest
(10%). The lateral resolution of NanoSIMS, <100 nm38 did not
permit the detailed visualization of smaller pores. Outside of
the larger clusters, these appeared as high ratio constellations
spread across the imaged areas thus supporting the mechanism
of continuous and heterogeneous peptide migration (Fig. 4C).
Consistent with this, mass spectrometry and gel electrophoresis
analyses of tilamin-treated DLPC/DLPG (3 : 1) AUVs that were
subjected to amine-specic cross-linking returned broad mass
distributions (Fig. S8A–C†).39 The lowest oligomeric forms that
could be assigned comprised 4–7 monomers. These oligomers
correlated well with the constellations observed by NanoSIMS
and the smallest pores of 5–10 nmmeasured by AFM in aqueous
solution (Fig. S8D†). Quantied size distributions at diﬀerent
depths below the membrane surface to ensure consistency in
measurements gave mean radii of the smallest pores in the
range of 1–6 nm, i.e. mean diameters of 2–12 nm (Fig. S9†).Chem. Sci., 2017, 8, 1105–1115 | 1109
Fig. 4 Monolayer poration in reconstitutedmembranes. Topographic (AFM) and chemical (NanoSIMS) imaging of DLPC/DLPG (3 : 1, molar ratio)
SLBs. (A) In-air AFM topographic images with a cross-section along the highlighted line (green) shown for the inset. Colour scales: 3 nm for the
topography images; and 15 degrees for the phase image. Incubation conditions: 10 mM, pH 7.4, rt. (B) Topography of supported lipid bilayers
measured by AFM in aqueous solution during incubation with tilamin where 0 min corresponds to the time of tilamin injection. Colour scale:
3 nm. Incubation conditions: 1.8 mM, pH 7.4, rt. (C) SIMS images of 12C15N/12C14N ratio obtained for the tilamin-treated DLPC/DLPG
(3 : 1, molar ratio) SLBs, and expressed as hue saturation images, which are the sums of sequential images to enhance the statistical signiﬁcance
of the measured ratios. The rainbow scale changes from blue (natural abundance of 0.37%) to pink (10%). Insets for tilamin-treated bilayers
highlight pore clusters (middle and right), and no clusters in untreated bilayers (left). Incubation conditions: 10 mM, pH 7.4, rt.
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View Article OnlineMembranes as primary targets for tilamin
As shown in live bacteria, monolayer poration leads to the rapid
lysis of bacterial cells (Fig. 3 and S1–S3†). Yet, microorganisms
incorporate other structures and processes that can be potential
targets for tilamin. To further emphasize that lipid bilayers
themselves constitute the primary targets for tilamin, we per-
formed a synthetic version of the live-dead bacterial assays
using giant unilamellar vesicles (GUVs) and monitored tilamin
action in real time by uorescence microscopy. GUVs represent
minimum membrane models of biological cells and are
composed of a phospholipid bilayer membrane and an aqueous
interior.40 The same lipid composition of POPC/POPG
(3 : 1, molar ratio) was used. The resulting vesicles have no
interior targets, thereby excluding an intracellular mechanism,
and lack any other membrane components, which provides the
necessary focus on the lipid bilayers. A co-staining strategy was
applied to visualize the vesicles by selectively staining their1110 | Chem. Sci., 2017, 8, 1105–1115membranes (CellMask™) and interior (sulforhodamine B)
(Fig. 5 and Video S1†). Tilamin was found to rapidly disintegrate
the GUVs under the same timescales as observed in the other
experiments (Fig. 5, S10A and Video S2†). Carboxyuorescein-
labelled peptide co-localised with the membrane dye, but not
with the interior dye, conrming the membrane targeting
mechanism of tilamin (Fig. 5, S10B and Video S3†). To form
shallow pores (Fig. 4) tilamin has to splay the lipids in the outer
monolayer and induce positive membrane curvature that can
result in budding.41 The eﬀect was strikingly apparent for tila-
min-treated vesicles (Fig. 5, S10A and B†). It appears that by
intercalating in the outer leaet tilamin introduces hydration
shells that support long-range orientational correlations
between lipids in areas (pores) aﬀected by the peptide. This
enables these areas to bulge, resembling eﬀects observed along
the boundaries of liquid-ordered and liquid-disordered lipid
phases40 (Fig. 5 and S10†). This eﬀect then evolved into abruptThis journal is © The Royal Society of Chemistry 2017
Fig. 5 Tilamin-induced lysis of giant unilamellar vesicles. Fluorescencemicrograph of GUVs assembled from POPC/POPG (3 : 1, molar ratio) and
incubated in phosphate-buﬀered saline without (upper) and with (lower) tilamin (10 mM, L/P 100). Key: violet is CellMask™Deep Red staining GUV
membranes, red is for sulforhodamine B staining the interior of the GUVs, green is for carboxyﬂuorescein-labelled tilamin. See also corre-
sponding Videos S1 and S3.†
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View Article Onlinedye release, as opposed to a gradual leakage (Fig. S10A, Videos
S2 and S3†), with the continuous bulging of collapsed GUVs also
evident (Fig. S10C†). The latter suggests a scaﬀolding mecha-
nism, reminiscent to that of amphiphysin N-BAR domains
splaying lipids in the outer monolayer,41 which, possibly via
monolayer stalks, may promote the merger of positively curved
domains at the sites of coalescing tilamin pores. The observa-
tions on tilamin-induced poration and rupture of phospholipid
bilayers in live and reconstituted membranes are strikingly
consistent. The dimensions of the observed pores and the rates
of their formation were comparable in bacterial and synthetic
membranes, while the conserved depth proles of the pores and
the tilamin-induced budding in GUVs suggest a particular
orientation of the peptide in the outer leaet of the bilayer.Monolayer poration correlates with insertion mode
To clarify the insertionmode of tilamin, four tilamin sequences,
each deuterated at a single alanine (Fig. 1A), were subjected to
the geometric analysis of labelled alanines (GALA) by oriented
solid state NMR (ssNMR) spectroscopy42,43 (Fig. S11†). An overall
tilt of 70 (equivalent to 110 for the opposite terminus) with
respect to the membrane normal was derived from 2H quad-
rupolar splittings obtained for tilamin in DLPC/DLPG
(3 : 1, molar ratio) AUVs (Table S2†). With the peptide dynamics
being within the timescale of the NMRmeasurements, the tilted
helix appeared as an equilibrium ensemble of close angles
implying adaptability to variations in bilayer thickness. Indeed,
quadrupolar splittings obtained in the thicker POPC/POPG
(3 : 1, molar ratio) AUVs, gave comparable tilts (Tables S2–S4,
Fig. 6A and S12†).
The root-mean-square deviation (RMSD) plots combining
the 2H data with 15N spectra for tilamin labelled at the central
tyrosine residue, which provided additional orientational
constraints,44 gave overlapping regions of orientational and tilt
angles revealing two possible solutions of tilamin insertionThis journal is © The Royal Society of Chemistry 2017(Fig. S13A, B and Table S4†). Both solutions tilted by 20
relative to the bilayer plane, which makes helix insertion by the
N- or C-terminus equally possible. The inserting end of tilamin
for solution 1 (110) is the N-terminus, whereas for solution
2 (70) it is reversed (Fig. S13C and Table S4†). Simulated 2H
quadrupolar splittings using Spinach soware45 returned
close ts with the experimental data conrming the solutions
(Table S5, Fig. S14A and B†). Complementary to this, atomistic
molecular dynamics simulations of a single tilamin helix
inserted into the DLPC/DLPG (3 : 1) bilayer produced similar
angle distributions (110–130) aer simulations of 500 ns
(Fig. S14C†). Taken together these results are notable for two
reasons.
Firstly, the NMR-derived insertion angles match the depth
proles of monolayer pores measured by AFM. With the tilamin
helix (3.15 nm) at tilts of 70, 60 and 50 (or, equivalently, 110,
120 and 130 for the opposite terminus) with the respect to the
membrane normal, its projection onto the membrane normal
gives the insertion depths of 1.1, 1.6 and 2 nm, respectively
(Fig. 6B and S15†). These orientations yield helix projections of
2.4–3 nm in length in the membrane plane (Fig. 6B), thus giving
a minimum of 5–6 nm for a pore with two opposing helices
spanning its diameter. The span constitutes a half of a minimal
pore facing an opposite helix, i.e. 5–6 nm (Fig. 6B and S15†),
which is consistent with the smallest pores of 5–10 nm assem-
bled from low peptide oligomers (Fig. S8†). Such low-oligomer
tilamin pores in POPC/POPG (3 : 1 molar ratio) bilayers were
simulated by coarse-grained molecular dynamics, which
revealed that transmembrane congurations were not stable:
individual peptides tended to move towards one leaet gener-
ating relatively symmetrical monolayer pores, which in newly
equilibrated atomistic model membranes46 appeared as
partially stabilized in the upper leaet (Fig. 6C).
Secondly, the palmitoyl POPC/POPG (3 : 1 molar ratio) and
live cell membranes contain unsaturated lipids, which alone
cannot support an orientational order,40,41 and their thicknessesChem. Sci., 2017, 8, 1105–1115 | 1111
Fig. 6 Tilamin insertion mode. (A) Oriented 2H NMR quadrupolar splittings (DvQ) in palmitoyl (POPC/POPG, 3 : 1 molar ratio) membranes for
tilamin deuterated (Ala-d3) at positions 19, 16, 9, 5 at a lipid-peptide (L/P) ratio 25. (B) A GALA-derived and MD-derived ensemble of helix tilt
angles for tilamin in the outer leaﬂet of the phospholipid bilayer showing tilt angles with corresponding insertion depths and horizontal spans of
the tilted helix. The helices are not to scale. The helix insertion by the C-terminus (solution 2) is shown (Table S4†). (C) A rudimentary
low-oligomer pore constructed by coarse-grained molecular dynamics simulations and converted to atomistic coordinates in a newly equili-
brated palmitoyl (POPC/POPG, 3 : 1 molar ratio) membrane. Membrane slabs are oriented to view the peptide tilts. Peptides, POPC and POPG
lipids are in blue, green and red, respectively. (D) Oriented 2H NMR quadrupolar splittings (DvQ) in palmitoyl (POPC/POPG, 3 : 1 molar ratio)
membranes for tilamin deuterated (Ala-d3) at position 9 at L/P ratios 100 and 50.
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View Article Onlineexceed the span of the folded tilamin. Therefore, the
membranes are unable to fully support transmembrane orien-
tation of the peptide without distorting the bilayer. The
dilauroyl DLPC/DLPG (3 : 1, molar ratio) membranes comprise
saturated lipids, are more densely packed and their thickness
(3.2 nm) can match the complete transmembrane span of the
folded tilamin.10,22 Despite such diﬀerences, tilamin promotes
the same poration mechanism in all the membranes used. The
tilted helix thus appears as an equilibrium conguration that
adapts in the outer layer of the bilayer by maintaining close
charge interplays with phospholipids. Supportive of this
conjecture ssNMR spectra obtained in deuterated palmitoyl
POPC/POPG (3 : 1 molar ratio) membranes showed greater
disordering eﬀects in lipid headgroup regions compared to tail
regions (Fig. S16†). In accord with this, continuous wave elec-
tron paramagnetic resonance (cwEPR) showed appreciable
reduction in amplitude of motion about the lipid chain axis at
the headgroup regions (Fig. S17†). At decreasing L/P ratios
(increasing peptide) tilamin induced clear segmental ordering1112 | Chem. Sci., 2017, 8, 1105–1115in lipids that were spin-labelled at the carboxyl ends (nitroxide
spin labelled phosphatidylcholine at position 5, 5-PCSL, versus
12-PCSL) (Fig. S17†). Similarly, the same decreasing L/P ratios
led to reduced 2H quadrupolar splittings reecting a more
pronounced membrane disruption upon binding more peptide
(Table S2, Fig. 6D, S16 and S18†).
Taken together the reduced amplitude of motion, observed
at the nanosecond timescale of cwEPR, and the disordering of
acyl chains, occurring at the microsecond timescale of 2H NMR,
suggest that tilamin tilts into the bilayer and perturbs its upper
leaet across a range of bio-molecular timescales. Atomistic
molecular dynamics simulations performed over 500 ns
conrmed the nature of tilamin binding as preferential inter-
actions between cationic residues and the anionic (PG)
components of the leaet (Fig. S19†). The simulations also
inferred a relative position of the tyrosine side chain in the
bilayer interface, which was consistent with the tilamin
conformation: the residue showed binding preferences similar
to those of the adjacent cationic residues (Fig. 1A, S20A†). GivenThis journal is © The Royal Society of Chemistry 2017
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View Article Onlineits central location in the peptide and in the tilt (0.55–1 nm
depth; and 1.2–1.5 nm span) the tyrosine should be buried in
the upper leaet (Fig. 6B). Gratifyingly, the intrinsic uores-
cence of tyrosine in both membrane types gave characteristic
red-shied increases suggesting a mixed type of interactions
in the distorted leaet, likely involving hydrogen bonding to
phosphate groups, hydrophobic interactions to tail regions and
cation–p interactions with the choline moieties of DLPC
(Fig. S20B†).Mechanistic rationale for antimicrobial monolayer poration
The results support our prediction for tilamin-induced poration
of the outer leaet of phospholipid bilayers as a molecular
mechanism for membrane disintegration resulting in rapid and
strong antimicrobial eﬀects. Such a mechanism is consistent
with other poration mechanisms of biological signicance.
For example, bacterial cassette transporters induce pore-like
perturbations in the cytosolic leaet of the membrane bilayer,47
whereas neurotoxic prion proteins tend to penetrate only a half
of mammalian membranes.48 Further, evidence exists for the
ability of individual bilayer leaets to independently regulate
membrane permeability in living systems.49
In this light, the mechanism of tilamin supports a distinct
antimicrobial process. This process is manifested in the rapid
assembly of antimicrobial peptides in the outer leaet of the
bilayer forming pore-like structures by inserting in a tilted
orientation. The resulting shallow pores impose energy penal-
ties that bacterial membranes cannot accommodate, but which
are compensated for by rapid membrane thinning and exfolia-
tion at the sites of pore formation. Such a state of monolayer
poration, an “M” state, is distinguished from hydrophilic
transmembrane pores, which can equilibrate, stabilize and
develop laterally (Fig. 7).
A transmembrane pore can also be viewed as a combination
of two porated monolayer interfaces merging into the more
favourable conguration of a hydrophilic hole.14 However, this
process would require peptides to attack from both the extra-Fig. 7 Proposed mechanism for antimicrobial monolayer poration.
Peptides (blue cylinders) bind to the membrane surface – “S”-state
(upper), and insert with forming pores in the outer leaﬂet of the bilayer
– “M” state (lower).
This journal is © The Royal Society of Chemistry 2017and intra-cellular sides of the bilayer, implying that peptide
translocation and engagement with the inner leaet should
occur at rates faster than those necessary for disrupting the
outer leaet – the rst and primary target of antimicrobial
peptides. Although possible at non-antimicrobial concentra-
tions,14 this scenario may not reect the biological rationale
of AMPs, which are overexpressed by cells at inammatory
sites,50 and whose primary role is to kill microbial cells before
proteolytic degradation. The faster AMPs rupture microbial
membranes, the more eﬃcient they are. Shallow pores formed
in the outer leaet need not expand or stabilize to lyse microbial
cells. The energetically unfavourable conguration they cause
by exposing the hydrophobic core of the bilayer to water is
unlikely to be mitigated by resealing51 or trans-bilayer (ip-op)
lipid re-arrangements52 observed for transmembrane pores in
synthetic bilayers, because the exfoliation of the outer leaet
leaves only an inner leaet, both sides of which, intra- and
extracellular, are exposed to water. Subsequently, this causes
the localised membrane rupture, accompanied by the forma-
tion of larger and deeper lesions and holes, which constitute the
functional hallmark of monolayer poration. For this reason, in
live cells monolayer pores appeared as short-lived, but forming
continuously and in abundance. Pores in SLBs can be expected
to form within the same timescale, which they did, but their
stability is dened by a higher activation barrier needed to ip
or remove lipids of the lower leaet from the substrate. Indeed,
supported lipid monolayers can remain stable over days in
water despite it not being an equilibrium conguration,37 which
suggests that monolayer pores in SLBs become kinetically
arrested in a sub-gel phase.38
Nonetheless, in all cases – live cells, SLBs and GUVs – tila-
min helices are likely to disrupt not only the membrane but
also the hydrogen-bond network of associated water, which
may also be reected in the central doublet in the 2H NMR
spectra being less resolved with decreasing L/P ratios (Fig. 6D).
The helices then can be viewed as hydration shells that
progressively intercalate in the outer leaet and cause orien-
tational correlations between lipids in the areas of increased
tilamin concentrations – shallow pores (Fig. 4 and 5). By
contrast, phospholipid bilayers alone, and particularly those
composed of unsaturated lipids that have a greater variety of
congurations, lack such long-range correlations.40 Hydrated
tilamin helices might lower the free energy penalty for exposing
the hydrophobic core in shallow pores, which may explain the
relative stability of these pores within the timescales observed.
However, the pores form with abundance and coalesce trig-
gering sharp increases in positive membrane curvature that
lead to signicant membrane thinning and bulging.41 The
abrupt and total rupture of the membrane is an invariable
consequence.
With respect to the mode of action, the rates of monolayer
poration appeared to directly correlate with bacterial kill rates
showing appreciable membrane thinning and exfoliation and
antimicrobial eﬀects in the same timescales. The action proved
to be folding-dependent and, as seen by NMR spectroscopy,
involves molecular dynamics at faster timescales, supporting
monolayer poration as a rapid and non-specic antimicrobialChem. Sci., 2017, 8, 1105–1115 | 1113
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View Article Onlinemechanism. Upon reaching critical concentrations on the
membrane surfaces tilamin splays the lipids in the outer leaet
of the bilayer, where it oligomerizes with the formation of
abundant shallow pores. Tilamin oligomers instantaneously
remove the outer layer of Gram negative cell walls, while
progressively porating their cytoplasmic membranes. Thicker
peptidoglycans on the surface of Gram positive bacteria, which
lack an outer membrane, might be expected to induce the
partial folding and pre-oligomerisation of the peptide before it
can reach the cytoplasmic membrane.53 Yet, this had no eﬀect
on antimicrobial activity, as tilamin did not diﬀerentiate
between Gram positive and Gram negative types (Table S1†).
In this regard, the non-diﬀerentiating mechanism of tilamin
that proved to be equally eﬀective in live bacteria and recon-
stituted anionic membranes can present a generic mode
of action that is independent of bacterial lipid compositions.
Indeed, lipids in diﬀerent microbial membranes can
vary signicantly.54 This underlies an intrinsic limitation of
synthetic membranes regardless of the chosen lipids and
therefore requires complementary live-bacteria measure-
ments. Most bacterial cells tend to maintain anionic PG
components in their membranes, whereas the choice for
zwitterionic lipids to distribute the negative charge is seem-
ingly arbitrary among diﬀerent organisms. For example, E. coli
is known to prefer phosphatidylethanolamine (PE), but
S. aureus is lacking the lipid completely.55 In P. aeruginosa it
mixes with phosphatidylcholines (PC), while double-
membrane spirochetes (B. burgdorferi) opt it out for PC.54
Perhaps even more importantly, emerging resistant strains
learn to incorporate lipids that are alien to their wild types
thus exploiting combinations that may provide them with
a competitive advantage.56
Conclusions
In summary, we have predicted, engineered and demonstrated
antimicrobial monolayer poration. Specically, our ndings
support a molecular mechanism whereby a tilted peptide
insertion triggers rapid and continuous membrane thinning
that is accompanied by the formation of monolayer pores
causing local membrane rupture. This mechanism was visual-
ised in live bacteria as well as reconstituted lipid bilayers
composed of saturated and unsaturated phospholipids used in
two formats – in solution and on supported lipid bilayers. In all
cases the mechanism consistently involved the rapid formation
of coalescing pores splaying the outer leaet of the lipid bila-
yers. The mechanism may advance our understanding of anal-
ogous naturally occurring phenomena including prion
porations and protein oligomerisation dynamics in membrane
leaets,47–49 while the described correlations between the
designed insertion mode, pore formation and antimicrobial
eﬀects emphasize antimicrobial peptides as a physical means of
innate host defense. As an archetypal molecular motif tilamin
folds and assembles in microbial membranes in a specic
orientation, which denes the rate and extent of membrane
disintegration, thus providing amechanistic basis for designing
more eﬀective antibiotics.1114 | Chem. Sci., 2017, 8, 1105–1115Acknowledgements
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